Nisa Investment Advisors’s CorMedix CRMD Stock Holding History

Nisa Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.68K	Buy	836 +37	+5%	+$273	﹤0.01%	2425
2025 Q4	$9.29K	Hold	799	–	–	﹤0.01%	2257
2025 Q3	$9.29K	Hold	799	–	–	﹤0.01%	2306
2025 Q2	$9.84K	Buy	799 +676	+550%	+$7.46K	﹤0.01%	2274
2025 Q1	$758	Hold	123	–	–	﹤0.01%	2706
2024 Q4	$996	Hold	123	–	–	﹤0.01%	2684
2024 Q3	$994	Hold	123	–	–	﹤0.01%	2580
2024 Q2	$533	Buy	+123	New	+$625	﹤0.01%	2670
2022 Q1	–	Sell	-7,414	Closed	-$31K	–	2361
2021 Q4	$31K	Buy	+7,414	New	+$36.8K	﹤0.01%	1839

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nisa Investment Advisors's CRMD Position: Q1 2026 in Review

Nisa Investment Advisors increased its CorMedix (CRMD) stake by 4.6% in Q1 2026, buying an estimated $273 and bringing the position to 836 shares worth $5.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

Nisa Investment Advisors first reported a position in CRMD in Q4 2021 and has held it in 9 quarters since. The position peaked at $31K in Q4 2021. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Nisa Investment Advisors held 836 shares of CorMedix worth $5.68K as of Q1 2026.
Nisa Investment Advisors bought 37 CorMedix shares in Q1 2026, an estimated $273.
CorMedix made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2425 holding.
Nisa Investment Advisors first reported a position in CorMedix in Q4 2021 and has held it in 9 quarters since.
Nisa Investment Advisors's CorMedix position peaked at $31K in Q4 2021.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.